TW338041B - Thiazole and imidazole derivatives and their use as a millard reaction inhibitor - Google Patents

Thiazole and imidazole derivatives and their use as a millard reaction inhibitor

Info

Publication number
TW338041B
TW338041B TW083101658A TW83101658A TW338041B TW 338041 B TW338041 B TW 338041B TW 083101658 A TW083101658 A TW 083101658A TW 83101658 A TW83101658 A TW 83101658A TW 338041 B TW338041 B TW 338041B
Authority
TW
Taiwan
Prior art keywords
alkyl
phenyl
alkoxyl
group
hydrogen atom
Prior art date
Application number
TW083101658A
Other languages
English (en)
Inventor
Koichi Yasumura
Keisuke Miyashima
Takao Nagahama
Shintaro Ishikawa
Yuko Toyama
Kazuhisa Sugiyama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of TW338041B publication Critical patent/TW338041B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW083101658A 1993-02-26 1994-02-26 Thiazole and imidazole derivatives and their use as a millard reaction inhibitor TW338041B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3772093 1993-02-26
JP23024393 1993-09-16

Publications (1)

Publication Number Publication Date
TW338041B true TW338041B (en) 1998-08-11

Family

ID=26376862

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083101658A TW338041B (en) 1993-02-26 1994-02-26 Thiazole and imidazole derivatives and their use as a millard reaction inhibitor

Country Status (14)

Country Link
US (1) US5677322A (zh)
EP (1) EP0638075B1 (zh)
JP (2) JP2821661B2 (zh)
KR (2) KR100250701B1 (zh)
CN (2) CN1037842C (zh)
AT (1) ATE212018T1 (zh)
AU (1) AU669427B2 (zh)
CA (1) CA2134347C (zh)
DE (1) DE69429641T2 (zh)
DK (1) DK0638075T3 (zh)
ES (1) ES2168294T3 (zh)
PT (1) PT638075E (zh)
TW (1) TW338041B (zh)
WO (1) WO1994019335A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
US5955617A (en) 1996-05-21 1999-09-21 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
WO1998043649A2 (en) * 1997-03-28 1998-10-08 Otsuka Pharmaceutical Co., Ltd. Age production inhibitory composition comprising a maillard reaction inhibitor and vitamin b¿6?
CA2664159C (en) 1998-08-24 2013-06-04 Toshio Miyata Carbonyl-stress improving agent and peritoneal dialysate
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
US6265571B1 (en) 1999-07-12 2001-07-24 Magellan Laboratories, Inc. Purification process for anti-parasitic fermentation product
DE10052590A1 (de) * 2000-10-24 2002-05-02 Haarmann & Reimer Gmbh Verwendung von 2-Hydrazino-1,3-thiazolen als Antioxidantien
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
EP1614680B1 (en) 2001-04-19 2011-12-21 Eisai R&D Management Co., Ltd. Process for preparing 2-iminopyrrolidine derivatives
WO2003004989A2 (en) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
ITRM20020016A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
CN100439336C (zh) 2003-02-19 2008-12-03 卫材R&D管理有限公司 制备环状苯甲脒衍生物的方法
US20050059790A1 (en) * 2003-09-16 2005-03-17 Roesler Richard R. Process for preparing aspartates
AU2004295047B2 (en) 2003-11-21 2011-03-10 Actelion Pharmaceuticals Ltd 5-(benz- (Z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
JPWO2005073180A1 (ja) * 2003-12-25 2008-01-10 株式会社クレハ ヒドロキサム酸誘導体、及び該誘導体を含むａｇｅ生成阻害剤
ES2523401T3 (es) * 2006-11-23 2014-11-25 Actelion Pharmaceuticals Ltd. Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
CA2895172C (en) 2012-08-17 2020-08-18 Actelion Pharmaceuticals Ltd Process for the preparation of|(2z,5z)-5-(3-chloro-4-((r)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-|(o-tolyl)thiazolidin-4-one and intermediate used in said process
GB201405991D0 (en) * 2014-04-03 2014-05-21 Cambridge Entpr Ltd Novel compounds
CN107459496B (zh) * 2016-06-03 2022-07-19 华东理工大学 噻唑类衍生物在治疗病毒感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528844A1 (fr) * 1982-06-18 1983-12-23 Chauvin Blache Lab Nouvelles thiazolyl-2 hydrazones, leur procede de preparation et leur application en therapeutique
US5258381A (en) * 1984-03-19 1993-11-02 The Rockefeller University 2-substituted-2-imidazolines
EP0325936A3 (en) * 1988-01-16 1990-01-17 Ono Pharmaceutical Co., Ltd. Aminoguanidine derivatives and inhibitory agents on maillard reaction containing them as active ingredients
TW221689B (zh) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd

Also Published As

Publication number Publication date
AU669427B2 (en) 1996-06-06
PT638075E (pt) 2002-06-28
JPH07133264A (ja) 1995-05-23
DE69429641D1 (en) 2002-02-21
ES2168294T3 (es) 2002-06-16
EP0638075A1 (en) 1995-02-15
DK0638075T3 (da) 2002-02-18
WO1994019335A1 (en) 1994-09-01
CN1184105A (zh) 1998-06-10
CN1037842C (zh) 1998-03-25
CN1106982A (zh) 1995-08-16
DE69429641T2 (de) 2002-08-29
JP2821661B2 (ja) 1998-11-05
CA2134347C (en) 2003-04-29
ATE212018T1 (de) 2002-02-15
KR950701328A (ko) 1995-03-23
JPH10167965A (ja) 1998-06-23
AU6045894A (en) 1994-09-14
CA2134347A1 (en) 1994-08-27
KR100257180B1 (ko) 2000-05-15
KR100250701B1 (ko) 2000-07-01
CN1067992C (zh) 2001-07-04
EP0638075B1 (en) 2002-01-16
US5677322A (en) 1997-10-14

Similar Documents

Publication Publication Date Title
TW338041B (en) Thiazole and imidazole derivatives and their use as a millard reaction inhibitor
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
NZ514095A (en) Amide compounds and medicinal use thereof
NZ523554A (en) Amino alcohol derivatives
MXPA02002720A (es) Nuevos compuestos de alfa-aminoacido-sulfonilo, un proceso para su preparacion y composiciones farmaceuticas que los comprenden.
GR3006247T3 (zh)
MX9703282A (es) Bencilglicosidos polianionicos como inhibidores de la proliferacion de las celulas del musculo liso.
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
HUT46313A (en) Process for producing 3/2h/-pyridazine derivatives and pharmaceutical compositions containing them as active components
CA2327673A1 (en) Aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists
HUT56089A (en) Process for producing quinazoline derivatives and pharmaceutical compositions containing them
GB1286315A (en) Thiazine, thiazoline and thiazolidine derivatives
ES2006076A6 (es) Procedimiento de preparacion de nuevos derivados peptidos de estructura policiclica nitrogenada.
EP0921122A4 (en) NEW EPOXYSUCCINAMIDE DERIVATIVES AND ASSOCIATED SALTS
ES8605810A1 (es) Un procedimiento para la preparacion de compuestos de beta-lactama
BG105123A (en) Tetrahydroquinaline derivatives as glycine antagonists
EP1188755A4 (en) ACYLHYDRAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
MY136694A (en) New thiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
HUP9902149A2 (hu) Antibakteriális hatású 1-metil-karbapenem-származékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
ES8801205A1 (es) Un procedimiento para la produccion de una isatina y una sal de la misma
DE69007356D1 (de) Zyklisches Tetrapeptid und Verfahren zu dessen Herstellung.
NZ505110A (en) Neuroprotective agents
GR3018798T3 (en) Pyrrolo [2,1-b]thiazole derivatives
AU3339800A (en) Agent for use in transplantation